Steven Lund - Nu Skin Executive Chairman of the Board
| NUS Stock | USD 7.56 1.14 17.76% |
Chairman
Mr. Steven J. Lund is the Executive Chairman of the Board of Nu Skin Enterprises, Inc. Mr. Lund has served as the Chairman of the Board since 2012. Mr. Lund previously served as Vice Chairman of the Board from 2006 to 2012. Mr. Lund served as President, Chief Executive Officer and a director of our company from 1996, when our company went public, until 2003, when he took a threeyear leave of absence. Mr. Lund was a founding stockholder of our company. Mr. Lund is a trustee of the Force for Good Foundation, a charitable organization that our company established in 1996 to help encourage and drive the philanthropic efforts of our company, its employees, its sales force and its customers to enrich the lives of others since 2012.
| Age | 71 |
| Tenure | 13 years |
| Address | 75 West Center Street, Provo, UT, United States, 84601 |
| Phone | 801 345 1000 |
| Web | https://www.nuskin.com |
Nu Skin Management Efficiency
The company has Return on Asset of 0.0342 % which means that on every $100 spent on assets, it made $0.0342 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.199) %, meaning that it generated no profit with money invested by stockholders. Nu Skin's management efficiency ratios could be used to measure how well Nu Skin manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to gain to -0.11 in 2025. Return On Capital Employed is likely to gain to -0.12 in 2025. At this time, Nu Skin's Non Current Assets Total are comparatively stable compared to the past year. Non Currrent Assets Other is likely to gain to about 104.3 M in 2025, whereas Other Current Assets are likely to drop slightly above 69.5 M in 2025.Similar Executives
| Found 8 records | CHAIRMAN Age | ||
| Philippe Benacin | Inter Parfums | 66 | |
| John Wiehoff | Polaris Industries | 59 | |
| Jean Madar | Inter Parfums | 64 | |
| Michael Johnson | Herbalife Nutrition | 70 | |
| Scott Wine | Polaris Industries | 52 | |
| Myron Wentz | USANA Health Sciences | 84 | |
| Kevin Guest | USANA Health Sciences | 62 | |
| George Deese | Flowers Foods | 74 | |
Management Performance
| Return On Equity | -0.2 | ||||
| Return On Asset | 0.0342 |
Nu Skin Enterprises Leadership Team
Elected by the shareholders, the Nu Skin's board of directors comprises two types of representatives: Nu Skin inside directors who are chosen from within the company, and outside directors, selected externally and held independent of NUS. The board's role is to monitor Nu Skin's management team and ensure that shareholders' interests are well served. Nu Skin's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Nu Skin's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Scott Pond, Director - Investor Relations | ||
| Ritch Wood, CFO, Principal Accounting Officer and VP | ||
| Chayce Clark, Executive Vice President General Counsel | ||
| Joseph Chang, Executive Vice President - Product Development, Chief Scientific Officer | ||
| Ruth Todd, Senior Officer | ||
| Emma Battle, Director | ||
| Thomas Pisano, Independent Director | ||
| Mark Adams, Chief Officer | ||
| Zheqing Shen, Independent Director | ||
| James Thomas, Chief Accounting Officer | ||
| Mang Tang, Strategic Advisor | ||
| Joe Sueper, Senior CTO | ||
| Mark Lawrence, Chief Financial Officer, Executive Vice President | ||
| Sandra Tillotson, Founder | ||
| D Dorny, Executive Vice President, General Counsel, Secretary | ||
| Steve Hatchett, Executive Officer | ||
| Daniel Campbell, Lead Independent Director | ||
| Edwina Woodbury, Independent Director | ||
| Laura Nathanson, Independent Director | ||
| Steven Lund, Executive Chairman of the Board | ||
| Matthew Dorny, VP, General Counsel and Secretary | ||
| Connie Tang, Executive Vice President Chief Global Growth & customer Experience Officer | ||
| Justin Keisel, President Americas | ||
| Blake Roney, Founder | ||
| Steven JD, CoFounder Board | ||
| Andrew Lipman, Independent Director | ||
| Greg Belliston, Assistant Secretary | ||
| Ryan Napierski, President, Chief Executive Officer, Director |
NUS Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Nu Skin a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.2 | ||||
| Return On Asset | 0.0342 | ||||
| Profit Margin | (0.08) % | ||||
| Operating Margin | (0.02) % | ||||
| Current Valuation | 630.63 M | ||||
| Shares Outstanding | 49.81 M | ||||
| Shares Owned By Insiders | 2.28 % | ||||
| Shares Owned By Institutions | 77.19 % | ||||
| Number Of Shares Shorted | 2.55 M | ||||
| Price To Earning | 10.70 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for NUS Stock Analysis
When running Nu Skin's price analysis, check to measure Nu Skin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nu Skin is operating at the current time. Most of Nu Skin's value examination focuses on studying past and present price action to predict the probability of Nu Skin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nu Skin's price. Additionally, you may evaluate how the addition of Nu Skin to your portfolios can decrease your overall portfolio volatility.